The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The Facilities for Illness Management and Prevention (CDC) at the moment introduced first-year funding awards of $215 million in a 5-year, $1.1 billion...
Printed: July 9, 2024Written by: Beth DoughertyDoctor-scientist Franziska Wachter, MD, got here to Dana-Farber 10 years in the past as a postdoctoral fellow...
